Literature DB >> 21970312

Might pentoxifylline have a role as adjuvant therapy for patients with giant cell arteritis?

Francisco José Fernández-Fernández.   

Abstract

Entities:  

Mesh：

Year:  2011        PMID： 21970312     DOI： 10.2165/11596480-000000000-00000

Source DB:  PubMed          Journal:  Drugs Aging        ISSN： 1170-229X            Impact factor:   3.923


× No keyword cloud information.
  4 in total

1.  Inhibition of human interleukin-12 production by pentoxifylline.

Authors:  D R Moller; M Wysocka; B M Greenlee; X Ma; L Wahl; G Trinchieri; C L Karp
Journal:  Immunology       Date:  1997-06       Impact factor: 7.397

Review 2.  Polymyalgia rheumatica and giant cell arteritis in older patients: diagnosis and pharmacological management.

Authors:  Jean Schmidt; Kenneth J Warrington
Journal:  Drugs Aging       Date:  2011-08-01       Impact factor: 3.923

3.  Pentoxifylline inhibits the synthesis and IFN-gamma-inducing activity of IL-18.

Authors:  T Samardzic; V Jankovic; S Stosic-Grujicic; D Popadic; V Trajkovic
Journal:  Clin Exp Immunol       Date:  2001-05       Impact factor: 4.330

Review 4.  IFN-γ and IL-17: the two faces of T-cell pathology in giant cell arteritis.

Authors:  Cornelia M Weyand; Brian R Younge; Jörg J Goronzy
Journal:  Curr Opin Rheumatol       Date:  2011-01       Impact factor: 5.006
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.